Navigation Links
Britain’s cancer initiatives leap forward with a miracle dru

A miracle drug is beginning to light up the lives of thousands of cancer patients, with hope for treating two severe cancers of the kidney and the gut.// Initial examinations of the drug have left a clue of its future use in breast, lung and pancreatic cancers.

This drug called Sutent, nicknamed as the “smart” drug works by nipping an important enzyme that causes the cells to proliferate rapidly, as is the case in some cancers. Further Sutent ensures that tumors run dry of nutrients, thus curbing its growth and development. This is perhaps the first drug of its kind that comprises a dual action.

Paul Nathan, a consultant oncologist at Mount Vernon Cancer Center in Northwood, Northwest London, said: “We have a couple of hundred new kidney cancer patients each year. I’d expect to treat about 50 each year with Sutent. This drug and others like it, we think, are a very major advance in the treatment of this disease.”

Judith Robinson, from the charity GIST Support UK, said: “Sutent is the first drug shown to be effective in patients with advanced GIST where the current standard of care has failed. For patients it can offer precious extra months of life.”

Presently the license for Sutent entails its use in treating kidney cancer and gastrointestinal stromal tumours (GIST). This drug is not easy on the pocket, costing about £2,400 per patient on a monthly basis. There is concern that the high cost of this drug might cause NHS to be careful in its use.
'"/>




Page: 1

Related medicine news :

1. Britain’s Hearts in Good Care – Deaths Due to Heart Disease Falls by 3%
2. Britain’s Mental Health Scene Encouragin
3. Vitamin B12 can help in detecting cancers
4. Want skin cancer? Please have a cigarette
5. New hope for cancer victims – will vaccine cure the deadly bug
6. Clintons new problem - Is the outgoing American president suffering from skin cancer?
7. Are cancer patients being taken for a ride?
8. Breast cancer treatment to be determined by gene test
9. Ductal lavage may detect early breast cancer
10. Beware of the oral patch! It could be cancer!!!
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Britain cancer initiatives leap forward with miracle dru

(Date:6/29/2015)... ... June 29, 2015 , ... Scientists from ... to build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping. ... for their association with human disease, but previously difficult to detect. The study ...
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a ... certain neuropsychiatric and chronic pain conditions, has announced appointments to three key leadership ... Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice ...
(Date:6/29/2015)... ... June 29, 2015 , ... OR Manager announced Monday the launch of an ... well as a redesigned logo and weekly eLetter. The website contains the same informational ... and easier to navigate. , In addition to a refreshed look, http://www.ormanager.com ...
(Date:6/29/2015)... ... 29, 2015 , ... Bionops Laboratories has released the first ... consumers. , The specialized eye health formulation contains a variety of ingredients to ... addition to Citicoline (Cognizin®), Biomacula provides necessary doses of Vitamin E, Glutathione, Resveratrol, ...
(Date:6/29/2015)... ... June 29, 2015 , ... FACE is proud to be one of ... reduction of the double chin and redefining of the jawline. Excess fat under ... older and heavier causing the person distress and poor self-image. , Kybella was produced ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:OR Manager Launches New Website 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2
... single nucleotide polymorphisms (SNPs), that are associated with a ... breast cancer do not appear to substantially improve the ... predict an individual,s risk, according to a study in ... of the National Cancer Institute . , Risk prediction ...
... Pittsburgh-led researchers could provide new insight into how ... arteriovenous malformations (AVMs)develop in humans, as reported in ... . , Led by Beth Roman, an assistant ... Arts and Sciences, the team created the first ...
... yet to show drop-off in access predicted by critics ... have not lost access to care despite federal legislation ... years, a new report finds. , Critics feared the ... make treatment more difficult, but investigators from the Duke ...
... current assessments, report says , , TUESDAY, July 8 (HealthDay ... in the ankle and the arm can help improve ... other cardiovascular problems, an international research group reports. ... is extremely easy to perform and doesn,t require expensive, ...
... blizzard of health-related,information, consumers and medical practitioners ... good from bad and keep up-to-date on ... leader in,enterprise search, recently published three case ... new search technologies to better,serve their users ...
... factor that keeps muscles from getting too big may optimize ... two myostatin inhibitors in mice with limb injuries, first to ... delivery mechanism, says Dr. Mark Hamrick, bone biologist in the ... , "Fifty to 60 percent of the injuries occurring ...
Cached Medicine News:Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Pitt-led research provides insight into development of congenital circulatory defects 2Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2Health News:Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk 2Health News:Vivisimo Case Studies Detail Innovative Enterprise Search Applications by Medical Libraries, Women's Health Site 2Health News:Vivisimo Case Studies Detail Innovative Enterprise Search Applications by Medical Libraries, Women's Health Site 3Health News:Myostatin inhibitors may improve recovery of wartime limb injuries 2Health News:Myostatin inhibitors may improve recovery of wartime limb injuries 3
(Date:6/29/2015)... ZIONA, Israel , June 29, ... BVXV, TASE: BVXV) today announced positive preliminary results from ... candidate for a universal influenza vaccine. In this trial, ... of 50 to 65, followed by an administration of ... later. M-001 was found to be safe and well ...
(Date:6/29/2015)... Calif. , June 29, 2015  Isis Pharmaceuticals, ... has been added to the Russell 1000 Index, effective ... performance of the large-cap segment of the U.S. equity ... Index and includes approximately 1000 of the largest securities ... current index membership. "We are pleased to ...
(Date:6/29/2015)... Calif. , June 29, 2015  Arbor ... medical workstation lineup. The high-powered, multi-functional M2150 ... generation Intel® Haswell Core i5-4402E 1.6 ... provide significant data processing and computing performance. Integrated ... making the unit well suited for graphics-intense applications ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... , CHEYENNE, Wyo., Aug. 24 The ... of its Pay-for-Participation (P4P) program, a component of its innovative ... collaboration between the practitioner community and the Wyoming EqualityCare (EC) ... Wyoming Medicaid members. , , (Logo: ...
... Curemark Founder and CEO Dr. Joan Fallon delivered the ... Conference at Harvard Medical School on July 14th. , ... conclave is particularly significant, since epigenetics is the study of ... in the DNA sequence. Presenters at the session showcased many ...
Cached Medicine Technology:Wyoming Department of Health's Pay-for-Participation Program Reports Positive Clinical Outcomes 2Wyoming Department of Health's Pay-for-Participation Program Reports Positive Clinical Outcomes 3Curemark CEO Presents at Epigenomics Conference 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: